Advertisement

Neurocritical Care

, Volume 16, Issue 1, pp 82–87 | Cite as

Early Platelet Transfusion Improves Platelet Activity and May Improve Outcomes After Intracerebral Hemorrhage

  • Andrew M. NaidechEmail author
  • Storm M. Liebling
  • Neil F. Rosenberg
  • Paul F. Lindholm
  • Richard A. Bernstein
  • H. Hunt Batjer
  • Mark J. Alberts
  • Hau C. Kwaan
Original Article

Abstract

Background

In patients with acute intracerebral hemorrhage (ICH), reduced platelet activity on admission predicts hemorrhage growth and poor outcomes. We tested the hypotheses that platelet transfusion improves measured platelet activity. Further, we hypothesized that earlier treatment in patients at high risk for hemorrhage growth and poor outcome would reduce follow-up hemorrhage size and poor clinical outcomes.

Methods

We prospectively identified consecutive patients with ICH who had reduced platelet activity on admission and received a platelet transfusion. We defined high-risk patients as per a previous publication, reduced platelet activity, or known anti-platelet therapy (APT) and the diagnostic CT within 12 h of symptom onset. Platelet activity was measured with the VerifyNow-ASA (Accumetrics, CA), ICH volumes on CT with computerized quantitative techniques, and functional outcomes with the modified Rankin Scale (mRS) at 3 months.

Results

Forty-five patients received a platelet transfusion with an increase in platelet activity from 472 ± 50 (consistent with an aspirin effect) to 561 ± 92 aspirin reaction units (consistent with no aspirin effect, P < 0.001). For high-risk patients, platelet transfusion within 12 h of symptom onset, as opposed to >12 h, was associated with smaller follow-up hemorrhage size (8.4 [3–17.4] vs. 13.8 [12.3–62.5] ml, P = 0.04) and increased odds of independence (mRS < 4) at 3 months (11 of 20 vs. 0 of 7, P = 0.01). There were similar results for patients with known APT.

Conclusions

In patients at high risk for hemorrhage growth and poor outcome, early platelet transfusion improved platelet activity assay results and was associated with smaller final hemorrhage size and more independence at 3 months.

Keywords

Intracerebral hemorrhage Platelets Outcomes 

Notes

Acknowledgments

Northwestern University has applied for a use patent on desmopressin for the treatment of ICH based on peer-reviewed manuscripts by AMN; it is unclear if this has any financial value. The Office of Research at Northwestern University has determined that this does not pose a financial conflict of interest.

Conflict of interest

Andrew M. Naidech has received unrelated research support from Gaymar, Inc and Astellas Pharma US, and the Northwestern Memorial Foundation.

References

  1. 1.
    Brott T, Broderick J, Kathari R, Tomsick T, Sauerbeck L, Spilker J, Duldner J, Khoury J. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, Begtrup K, Steiner T, Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66:1175–81.PubMedCrossRefGoogle Scholar
  3. 3.
    Anderson C, Huang Y, Wang J, Arima H, Neal B, Peng B, Heeley E, Skulina C, Parsons M, Kim J, Tao Q, Li Y, Jiang J, Tai L, Zhang J, Xu E, Cheng Y, Heritier S, Morgenstern L, Chalmers J. Intensive blood pressure reduction in acute cerebral haemorrhage trial (interact): a randomised pilot trial. Lancet Neurol. 2008;7:391–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Mayer SA, Brun NC, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T. Efficacy and safety of recombinant activated factor vii for acute intracerebral hemorrhage. New Engl J Med. 2008;358:2127–37.PubMedCrossRefGoogle Scholar
  5. 5.
    Roquer J, Rodriguez-Compello A, Gomis M, Ois A, Munteis E. Previous anti-platelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage. J Neurol. 2005;252:412–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Saloheimo P, Ahonen M, Juvela S, Pyhtinen J, Savolainen E, Hillborm M. Regular aspirin use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke. 2006;37:129–33.PubMedCrossRefGoogle Scholar
  7. 7.
    Thompson BB, Bejot Y, Caso V, Castillo J, Christensen H, Flaherty ML, Foerch C, Ghandehari K, Giroud M, Greenberg SM, Hallevi H, Hemphill JC 3rd, Heuschmann P, Juvela S, Kimura K, Myint PK, Nagakane Y, Naritomi H, Passero S, Rodriguez-Yanez MR, Roquer J, Rosand J, Rost NS, Saloheimo P, Salomaa V, Sivenius J, Sorimachi T, Togha M, Toyoda K, Turaj W, Vemmos KN, Wolfe CD, Woo D, Smith EE. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology. 2010;75:1333–42.PubMedCrossRefGoogle Scholar
  8. 8.
    Naidech AM, Jovanovic B, Liebling S, Garg RK, Bassin SL, Bendok BR, Bernstein RA, Alberts MJ, Batjer HH. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke. 2009;40:2398–401.PubMedCrossRefGoogle Scholar
  9. 9.
    Morgenstern LB, Hemphill JC, Tamargo RJ, Anderson C, Becker K, Broderick JP, Connolly ES, Greenberg SM, Huang JN, MacDonald RL, Messe SR, Mitchell PH, Selim M. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108–29.PubMedCrossRefGoogle Scholar
  10. 10.
    de Gans K, de Haan RJ, Majoie CB, Koopman MM, Brand A, Dijkgraaf MG, Vermeulen M, Roos YB. Patch: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial. BMC Neurol. 2010;10:19.PubMedCrossRefGoogle Scholar
  11. 11.
    Goldstein JN, Rosand J, Schwamm LH. Warfarin reversal in anticoagulant-associated intracerebral hemorrhage. Neurocrit Care. 2008;9:277–83.PubMedCrossRefGoogle Scholar
  12. 12.
    Vlaar APJ, Binnekade JM, Prins D, van Stein D, Hofstra JJ, Schultz MJ, Juffermans NP. Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case–control study. Crit Care Med. 2010;38:771–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Morrow JF, Braine HG, Kickler TS, Ness PM, Dick JD, Fuller AK. Septic reactions to platelet transfusions. JAMA. 1991;266:555–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Platelet transfusion therapy—consensus conference. JAMA. 1987;257:1777–80.Google Scholar
  15. 15.
    Sorimachi T, Fujii Y, Morita K, Tanaka R. Predictors of hematoma enlargement in patients with intracerebral hemorrhage treated with rapid administration of antifibrinolytic agents and strict blood pressure control. J Neurosurg. 2007;106:250–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, Mayberg M, Morgenstern L, Ogilvy CS, Vespa P, Zuccarello M. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38:2001–23.PubMedCrossRefGoogle Scholar
  17. 17.
    Wilson JTL, Hareendran A, Grant M, Baird T, Schulz UGR, Muir KW, Bone I. Improving the assessment of outcomes in stroke: use of a structured interview to assign grade on the modified Rankin scale. Stroke. 2002;33:2243–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Banks J, Marotta C. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38:1091–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Karon B, Wockenfus A, Scott R, Hartman S, McConnell J, Santrach P, Jaffe A. Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. Clin Chem. 2008;54:1060–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Lordkipanidze M, Pharand C, Schampaert E, Turgeon J, Palisaitis D, Diodati J. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J. 2007;28:1702–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Hillbom M, Huhtakangas J. Platelet transfusion in acute intracerebral hemorrhage. Clinicaltrials.Gov number nct00699621. Available at http://www.clinicaltrials.gov/ct2/show/NCT00699621?term=platelet+transfusion+intracerebral+hemorrhage&recr=Open&rank=1. Accessed 25 July 2008.
  22. 22.
    Goldenberg NA, Jacobson L, Manco-Johnson MJ. Brief communication: duration of platelet dysfunction after a 7-day course of ibuprofen. Ann Intern Med. 2005;142:506–9.PubMedGoogle Scholar
  23. 23.
    Vespa PM. Blood pressure after intracerebral hemorrhage: lower may not be safer. Crit Care Med. 2010;38:731–2.PubMedCrossRefGoogle Scholar
  24. 24.
    Schwarz S, Hafner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology. 2000;54:354–61.PubMedGoogle Scholar
  25. 25.
    Creutzfeldt CJ, Weinstein JR, Longstreth WT Jr, Becker KJ, McPharlin TO, Tirschwell DL. Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2009;18:221–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Zahuranec DB, Brown DL, Lisabeth LD, Gonzales NR, Longwell PJ, Smith MA, Garcia NM, Morgenstern LB. Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology. 2007;68:1651–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Becker KJ, Baxter AB, Cohen WA, Bybee HM, Tirschwell DL, Newell DW, Winn HR, Longstreth WT Jr. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology. 2001;56:766–72.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Andrew M. Naidech
    • 1
    Email author
  • Storm M. Liebling
    • 1
  • Neil F. Rosenberg
    • 1
  • Paul F. Lindholm
    • 1
  • Richard A. Bernstein
    • 1
  • H. Hunt Batjer
    • 1
  • Mark J. Alberts
    • 1
  • Hau C. Kwaan
    • 1
  1. 1.Department of NeurologyNorthwestern University’s Feinberg School of MedicineChicagoUSA

Personalised recommendations